A Novel Multifunctional Crosslinking PVA/CMCS Hydrogel Containing Cyclic Peptide Actinomycin X2 and PA@Fe with Excellent Antibacterial and Commendable Mechanical Properties
Chemistry & Biodiversity · 2023
DOI: 10.1002/cbdv.202300831 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2023. Verfasst von Fengyun Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Chemical Engineering, Zhejiang Sci-Tech University, Hangzhou, Zhejiang, 310018, China. Hauptthemen laut MEDLINE: Chitosan, Anti-Infective Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Agricultural Science and Technology Cooperation Project Fund of Zhejiang Province, National Natural Science Foundation of China, Key Research and Development Program of Zhejiang Province, China.
Abstract (Originalsprache)
Bacterial infected environments and resulting bacterial infections have been threatening the human health globally. Due to increased bacterial resistance caused by improper and excessive use of antibiotics, antibacterial biomaterials are being developed as alternatives to antibiotics in some cases. Herein, an advanced multifunctional hydrogel with excellent antibacterial properties, enhanced mechanical properties, biocompatibility and self‐healing performance, was designed through freezing‐thawing method. This hydrogel network is composed of polyvinyl alcohol (PVA), carboxymethyl chitosan (CMCS), protocatechualdehyde (PA), ferric iron (Fe) and an antimicrobial cyclic peptide actinomycin X2 (Ac.X2). The double dynamic bonds among protocatechualdehyde (PA), ferric iron (Fe) and carboxymethyl chitosan containing coordinate bond (catechol‐Fe) as well as dynamic Schiff base bonds and hydrogen bonds endowed the hydrogel with enhanced mechanical properties. Successful formation of hydrogel was confirmed through ATR‐IR and XRD, and structural evaluation through SEM analysis, whereas mechanical properties were tested with electromechanical universal testing machine. The resulting PVA/CMCS/Ac.X2/PA@Fe (PCXPA) hydrogel has favorable biocompatibility and excellent broad‐spectrum antimicrobial activity against both S. aureus (95.3 %) and E. coli (90.2 %) compared with free‐soluble Ac.X2, which exhibited subpar performance against E. coli reported in our previous studies. This work provides a new insight on preparing multifunctional hydrogels containing antimicrobial peptides as antibacterial material.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chemistry and Chemical Engineering, Zhejiang Sci-Tech University, Hangzhou, Zhejiang, 310018, China.
- Zhejiang Key Laboratory of Silkworm Bioreactor and Biomedicine, Laboratory of Antiallergic Functional Molecules, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, Zhejiang, 310018, China.
Förderung
- Agricultural Science and Technology Cooperation Project Fund of Zhejiang Province
- National Natural Science Foundation of China
- Key Research and Development Program of Zhejiang Province, China
Zitieren
APA
Chen, F., Javeed, A., Zeng, Q., Zhang, Q., & Han, B. (2023). A Novel Multifunctional Crosslinking PVA/CMCS Hydrogel Containing Cyclic Peptide Actinomycin X2 and PA@Fe with Excellent Antibacterial and Commendable Mechanical Properties. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202300831
Vancouver
Chen F, Javeed A, Zeng Q, Zhang Q, Han B. A Novel Multifunctional Crosslinking PVA/CMCS Hydrogel Containing Cyclic Peptide Actinomycin X2 and PA@Fe with Excellent Antibacterial and Commendable Mechanical Properties. Chemistry & Biodiversity. 2023. doi:10.1002/cbdv.202300831
BibTeX
@article{Chen2023,
author = {Chen, Fengyun and Javeed, Ansar and Zeng, Qiuyu and Zhang, Quan and Han, Bingnan},
title = {A Novel Multifunctional Crosslinking PVA/CMCS Hydrogel Containing Cyclic Peptide Actinomycin X2 and PA@Fe with Excellent Antibacterial and Commendable Mechanical Properties},
journal = {Chemistry & Biodiversity},
year = {2023},
doi = {10.1002/cbdv.202300831}
}
EUVIMED